We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-4.51%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$481M
AUM Growth
-$36.5M
Cap. Flow
-$7.21M
Cap. Flow %
-1.5%
Top 10 Hldgs %
70.42%
Holding
77
New
4
Increased
18
Reduced
37
Closed
9

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$9.69M
2
VTRS icon
Viatris
VTRS
+$3.15M
3
OGN icon
Organon & Co
OGN
+$2.13M
4
MO icon
Altria Group
MO
+$1.72M
5
OXY icon
Occidental Petroleum
OXY
+$1.59M

Sector Composition

Rank Sector Weight
1 Financials 37.1%
2 Energy 17.13%
3 Healthcare 16.46%
4 Technology 11.68%
5 Consumer Staples 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
51
United Therapeutics
UTHR
$22.2B
$492K 0.1%
2,350
-50
-2% -$11.2K
ABT icon
52
Abbott
ABT
$199B
$472K 0.1%
4,875
-50
-1% -$5.33K
MCD icon
53
McDonald's
MCD
$188B
$464K 0.1%
2,010
ITW icon
54
Illinois Tool Works
ITW
$81.1B
$428K 0.09%
2,370
SO icon
55
Southern Company
SO
$103B
$420K 0.09%
6,175
-100
-2% -$7.58K
ATVI
56
DELISTED
Activision Blizzard
ATVI
$398K 0.08%
+5,350
New +$419K
PM icon
57
Philip Morris
PM
$303B
$384K 0.08%
4,625
AXP icon
58
American Express
AXP
$227B
$290K 0.06%
2,150
BEN icon
59
Franklin Templeton
BEN
$17.8B
$286K 0.06%
13,293
-6,646
-33% -$171K
CHWY icon
60
Chewy
CHWY
$9.54B
$280K 0.06%
9,105
-10,660
-54% -$423K
JAZZ icon
61
Jazz Pharmaceuticals
JAZZ
$16.3B
$277K 0.06%
2,078
-2,105
-50% -$320K
WMB icon
62
Williams Companies
WMB
$90.9B
$268K 0.06%
9,375
-150
-2% -$4.89K
RKT icon
63
Rocket Companies
RKT
$39.5B
$263K 0.05%
+41,670
New +$362K
CSX icon
64
CSX Corp
CSX
$96.5B
$241K 0.05%
9,030
ZBH icon
65
Zimmer Biomet
ZBH
$19.3B
$227K 0.05%
2,170
-125
-5% -$13.7K
HP icon
66
Helmerich & Payne
HP
$4.11B
$219K 0.05%
5,915
+50
+0.9% +$2.1K
KMI icon
67
Kinder Morgan
KMI
$71.6B
$189K 0.04%
11,345
-2,045
-15% -$36.4K
NAT icon
68
Nordic American Tanker
NAT
$1.37B
$30K 0.01%
11,225
EFA icon
69
iShares MSCI EAFE ETF
EFA
$80B
-3,412
Closed -$213K
GD icon
70
General Dynamics
GD
$103B
-2,110
Closed -$467K
GIS icon
71
General Mills
GIS
$21.5B
-2,900
Closed -$219K
GSK icon
72
GSK
GSK
$103B
-30,524
Closed -$1.66M
IFF icon
73
International Flavors & Fragrances
IFF
$22.3B
-1,765
Closed -$210K
PBR icon
74
Petrobras
PBR
$116B
-11,800
Closed -$138K
PKX icon
75
POSCO
PKX
$17.7B
-8,505
Closed -$379K

Similar funds

Greylin Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Greylin Investment Management held 77 positions worth $481M, down 7.1% from $518M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Greylin Investment Management's Q3 2022 filing shows 4 new, 18 increased, 37 reduced and 9 closed positions. Its largest new stake was Ally Financial: 25,555 shares worth $711K. The largest sale was Walgreens Boots Alliance, an estimated $4.29M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q3 2022 buy was Ally Financial: 25,555 shares worth $711K.
  • Greylin Investment Management added most to Intel in Q3 2022, an estimated $9.69M increase.
  • Greylin Investment Management's biggest Q3 2022 reduction was Walgreens Boots Alliance, cutting an estimated $4.29M.
  • Greylin Investment Management fully exited GSK in Q3 2022, selling an estimated $1.66M.
  • Greylin Investment Management's ten largest holdings make up 70% of its $481M portfolio in Q3 2022.
  • Greylin Investment Management opened 4 new positions and closed 9 in Q3 2022.
  • Greylin Investment Management's portfolio value fell 7.1% quarter-over-quarter to $481M.

Based on Greylin Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.